Target intelligence / Profile preview

Nuclear pore complex interacting protein family member B5 (NPIPB5)

Target
NPIPB5
Molecular classification
Other (protein-coding; not a classic receptor, enzyme, transporter, channel, or transcription factor)
01

Overview

Nuclear pore complex interacting protein family member B5 (NPIPB5) is a protein-coding gene found in humans (gene ID 100132247) and encodes a predicted protein potentially associated with the nuclear pore complex (NPC), which is a large protein assembly responsible for transport between the nucleus and cytoplasm. NPIPB5 is detected at the transcriptomic level in a variety of tissues, and somatic mutations in NPIPB5 have been observed in several cancer types, though its function is not well understood and it is not currently established as a clinically relevant therapeutic target. There are no known drugs, biomarker roles, or safety concerns linked to NPIPB5 at this time. The broader family of nuclear pore complex proteins (nucleoporins) is essential for cellular transport and genome stability, but the specific contribution of NPIPB5 remains undefined. Key points: - Not a classical therapeutic target: It is not classified as a receptor, enzyme, transporter, or canonical drug target and is not currently implicated directly in therapeutic strategies. - Limited functional data: The gene is annotated as protein-coding; mutational analyses hint at possible relevance to malignancy, but functional significance is unknown. - Disease associations are preliminary: Somatic mutations are found in tumors, but causality and mechanistic roles remain unproven. - No approved drugs, biomarkers, or safety issues: No clinical or pre-clinical use is currently known.

Other names
NPIPB5Nuclear pore complex-interacting protein family member B5Nuclear pore complex interacting protein related
02

Mechanism of action

None known

03

Biological functions

Unknown/Other (The NPIPB5 gene encodes a protein thought to be associated with nuclear pore complex function, but its specific biological role has not yet been defined in detail)
04

Disease associations

Cancer (mutational data indicate somatic mutations in cancer, including breast, cervix, endometrium, colon, thyroid)Other (barely characterized; possible involvement in malignancy from transcriptomic studies)
05

Safety considerations

None established
06

Interacting drugs

None known (no drugs are reported to directly interact with NPIPB5)
07

Biomarkers

None established

Beyond the preview

Go deeper on Nuclear pore complex interacting protein family member B5 (NPIPB5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear pore complex interacting protein family member B5 (NPIPB5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call